Biomarkers for neuroplasticity, such as BDNF, and biomarkers for (synaptic) neurodegeneration (including neurofilament NfL and α-synuclein) are, respectively, decreased and increased in PD patients compared with age-matched controls (15–17). This evidence concerns the gene BDNF and Parkinson disease.